These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16181320)

  • 1. Pseudo-decidual reaction to Mirena coil in a cervical smear: a potential diagnostic pitfall for false-positive cervical cytology.
    Hughes C; Woods J; Turner L; Gibbons D
    Cytopathology; 2005 Oct; 16(5):268-9. PubMed ID: 16181320
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial adenocarcinoma in association with a levonorgestrel-releasing intrauterine system (Mirena).
    Ndumbe FM; Husemeyer RP
    J Fam Plann Reprod Health Care; 2006 Apr; 32(2):113-4. PubMed ID: 16824305
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mirena--the first intrauterine contraceptive therapeutic system].
    Rachev E
    Akush Ginekol (Sofiia); 2001; 40 Suppl 6():3-6. PubMed ID: 11803883
    [No Abstract]   [Full Text] [Related]  

  • 5. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 7. Endometrial granulomas with Levonorgestrel Intrauterine System (Mirena).
    Charlton F; Otton G; Hedges A; Scurry J
    Pathology; 2014 Aug; 46(5):457-8. PubMed ID: 24978028
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypertension and use of an intrauterine levonorgestrel-releasing device.
    Vos AG; van de Ree MA
    Neth J Med; 2012 Nov; 70(9):431. PubMed ID: 23123543
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IUDs and ectopic pregnancy.
    Sivin I
    Contraception; 1995 Nov; 52(5):321-2. PubMed ID: 8585891
    [No Abstract]   [Full Text] [Related]  

  • 11. Levonorgestrel intrauterine device (IUD) exacerbation of PMS symptoms.
    Appiani FJ; Carroll BT
    Ann Clin Psychiatry; 2014 May; 26(2):146-7. PubMed ID: 24812652
    [No Abstract]   [Full Text] [Related]  

  • 12. Intra-uterine progestogen system.
    Nurs Times; 2006 Apr 11-17; 102(15):36. PubMed ID: 16640212
    [No Abstract]   [Full Text] [Related]  

  • 13. Lawsuits against Mirena®: potential impact on public health.
    Danvers AA; Stuart GS; Bryant AG
    Contraception; 2014 Jun; 89(6):489-92. PubMed ID: 24768305
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case report. Sepsis in connection with levonorgestrel IUD].
    Ottander U; Bäckström T; Högberg U; Löfgren M
    Lakartidningen; 1995 Nov; 92(48):4555-7. PubMed ID: 7490972
    [No Abstract]   [Full Text] [Related]  

  • 15. [Connection between levonorgestrel-IUD and GAS (Group A Streptococcus) sepsis? Reliable risk assessment is not yet possible].
    Milsom I; Landgren BM; Alestig K
    Lakartidningen; 1995 Dec; 92(50):4781-2. PubMed ID: 8538290
    [No Abstract]   [Full Text] [Related]  

  • 16. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
    Harrison-Woolrych M; Zhou L; Coulter D
    N Z Med J; 2003 Aug; 116(1179):U538. PubMed ID: 14513085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exercise-induced oedema due to hormone-containing intrauterine device].
    Franssen LE; Bos WJ
    Ned Tijdschr Geneeskd; 2012; 156(45):A4978. PubMed ID: 23134748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine uterine contraception and chronic urticaria: a case series.
    Wunschel J; Poole JA
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):378-380. PubMed ID: 28111112
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.